CT
ELV icon

Chicago Trust’s Elevance Health ELV Stock Holding History

Chicago Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-587
Closed -$255K – 415
2025
Q1 		$255K Buy
+587
New +$236K 0.05% 315
2024
Q4 		– Sell
-1,667
Closed -$867K – 367
2024
Q3 		$867K Buy
1,667
+874
+110% +$467K 0.15% 137
2024
Q2 		$430K Buy
793
+16
+2% +$8.46K 0.09% 193
2024
Q1 		$403K Buy
777
+7
+0.9% +$3.48K 0.08% 203
2023
Q4 		$363K Buy
770
+157
+26% +$72.6K 0.08% 203
2023
Q3 		$267K Sell
613
-73
-11% -$33.1K 0.07% 239
2023
Q2 		$305K Buy
686
+36
+6% +$16.6K 0.07% 235
2023
Q1 		$299K Buy
650
+33
+5% +$15.7K 0.08% 225
2022
Q4 		$316K Sell
617
-5
-0.8% -$2.54K 0.08% 223
2022
Q3 		$282K Sell
622
-7
-1% -$3.35K 0.07% 230
2022
Q2 		$304K Buy
+629
New +$311K 0.08% 223
2021
Q3 		– Sell
-763
Closed -$291K – 332
2021
Q2 		$291K Buy
+763
New +$292K 0.07% 247

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Chicago Trust's ELV Position: Q2 2025 in Review

Chicago Trust sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 587 shares — an estimated $255K sold.

Chicago Trust first reported a position in ELV in Q2 2021 and held it in 12 quarters. The position peaked at $867K in Q3 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Chicago Trust reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Chicago Trust sold 587 Elevance Health shares in Q2 2025, an estimated $255K.
  • Chicago Trust first reported a position in Elevance Health in Q2 2021 and held it in 12 quarters.
  • Chicago Trust's Elevance Health position peaked at $867K in Q3 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Chicago Trust's 13F filing for Q2 2025, filed 14 Jul 2025.